insights_auto
Hvorfor er UCBJY faldet med 2,79%?
Dyk dybere nedchevron_right
UCBJY:OTCMKTS
UCB
110,78 US$
arrow_downward
-2,79%(-3,18) 1D
13. okt., 16.00.00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for UCBJY...
Åbn
113,65 US$
Høj
113,65 US$
Lav
110,55 US$
Markedsværdi
38,76 mia.
Gns. vol.
49,66 t
Volumen
80,87 t
Højeste i 52 uger
168,76 US$
Laveste i 52 uger
110,55 US$
Beta
0,57
Aktier i omløb
389,01 mio.
Antal ansatte
9 t
Åbn
113,65 US$
Høj
113,65 US$
Lav
110,55 US$
Markedsværdi
38,76 mia.
Gns. vol.
49,66 t
Volumen
80,87 t
Højeste i 52 uger
168,76 US$
Laveste i 52 uger
110,55 US$
Beta
0,57
Aktier i omløb
389,01 mio.
Antal ansatte
9 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
ad-hoc-news.de
·
for 2 timer siden
UCB dedicates Georgia site. UCB stock sits 30.78 percent below its high
ad-hoc-news.de
·
for 6 timer siden
UCB launches Wear It Out program: UCB stock pre-market at EUR 198.60
ad-hoc-news.de
·
for 1 dag siden
ING sets EUR 304.00 target for UCB stock with 48.87 percent upside
ad-hoc-news.de
·
for 1 dag siden
UCB stock pre-market at EUR 203.40
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Om UCB
Administrerende direktørJean-Christophe Tellier
Ansatte9 t
Grundlagt18. jan. 1928
Hovedsæde-
Sektor-
Websiteucb.com